Antalis T M, Costelloe E, Muddiman J, Ogbourne S, Donnan K
Queensland Cancer Fund Experimental Oncology Unit, Queensland Institute of Medical Research, Brisbane, Australia.
Blood. 1996 Nov 15;88(10):3686-97.
Transcriptional regulation of the plasminogen activator inhibitor type-2 (PAI-2) gene appears to be an important factor in the response of mononuclear phagocytes to inflammation. We have investigated here the molecular basis for PAI-2 synthesis in monocytic cells by reporter gene deletion analysis. A DNA fragment containing 5.1 kb of 5' flanking region through to the start of the second exon was fused to a chloramphenicol acetyl transferase (CAT) reporter gene, transfected into macrophage and nonmacrophage cells and tested for PAI-2 promoter-directed CAT activity in the presence and absence of phorbol ester. Deletion analysis showed the existence of three major transcription regulatory regions. (1) A positive regulatory region contained in the proximal promoter mediates basal transcription and 12-phorbol 13-myristate acetate inducibility. (2) A negative regulatory region, or silencer, present between -1977 and -1675, was found to repress PAI-2 promoter activity in an orientation- and position-independent manner, but not in a cell-specific manner. (3) A second positive regulatory element, located upstream between approximately -5100 and -3300, appears to overcome inhibition mediated by the silencer in a cell-specific manner, suggesting a mechanism for the regulation of this gene. We have localized the motif responsible for silencer activity to a 28-bp DNA sequence containing a unique 12-bp palindrome centered at an Xba I restriction enzyme site, CTCTCTAGAGAG, which is designated the PAI-2-upstream silencer element-1 (PAUSE-1). This element binds a specific PAUSE-1 binding factor as determined by mobility shift analysis. We conclude that PAI-2 gene transcription is regulated by both positive and negative control mechanisms that may be important for the regulation of other genes as well.
纤溶酶原激活物抑制剂2(PAI-2)基因的转录调控似乎是单核吞噬细胞对炎症反应的一个重要因素。我们在此通过报告基因缺失分析研究了单核细胞中PAI-2合成的分子基础。一个包含5.1 kb 5'侧翼区域直至第二个外显子起始处的DNA片段与氯霉素乙酰转移酶(CAT)报告基因融合,转染至巨噬细胞和非巨噬细胞中,并在有和没有佛波酯存在的情况下检测PAI-2启动子指导的CAT活性。缺失分析显示存在三个主要的转录调控区域。(1)近端启动子中包含的一个正调控区域介导基础转录和12-佛波醇13-肉豆蔻酸酯乙酸盐诱导性。(2)发现位于-1977至-1675之间的一个负调控区域或沉默子以方向和位置独立的方式抑制PAI-2启动子活性,但不是以细胞特异性方式。(3)位于大约-5100至-3300上游的第二个正调控元件似乎以细胞特异性方式克服由沉默子介导的抑制,提示了该基因的一种调控机制。我们已将负责沉默子活性的基序定位到一个28 bp的DNA序列,该序列包含一个以Xba I限制性酶切位点CTCTCTAGAGAG为中心的独特12 bp回文序列,被命名为PAI-2上游沉默子元件-1(PAUSE-1)。通过迁移率变动分析确定该元件结合一种特异性的PAUSE-1结合因子。我们得出结论,PAI-2基因转录受正调控和负调控机制调节,这对其他基因的调控可能也很重要。